Mayflower Financial Advisors, LLC Abb Vie Inc. Transaction History

Mayflower Financial Advisors, LLC

$629 Million
Q3 2024

A detailed history of Mayflower Financial Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mayflower Financial Advisors, LLC holds 15,994 shares of ABBV stock, worth $2.81 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

15,994

Previous 16,218 1.38%

Holding current value

$2.81 Million

Previous $2.78 Million 13.56%

% of portfolio

0.5%

Previous 0.21%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$163.84 - $199.33 $36,700 - $44,649	-224 Reduced 1.38%	15,994 $3.16 Million
Q2 2024 Aug 02, 2024	SELL	$154.79 - $180.76 $5,262 - $6,145	-34 Reduced 0.21%	16,218 $2.78 Million
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $12.5 Million - $14.3 Million	-78,439 Reduced 82.84%	16,252 $2.96 Million
Q4 2023 Jan 22, 2024	SELL	$137.6 - $154.97 $67,286 - $75,780	-489 Reduced 0.51%	94,691 $14.7 Million
Q3 2023 Oct 12, 2023	SELL	$133.59 - $154.65 $261,836 - $303,114	-1,960 Reduced 2.02%	95,180 $14.2 Million
Q2 2023 Jul 13, 2023	BUY	$132.51 - $164.9 $90,504 - $112,626	683 Added 0.71%	97,140 $13.1 Million
Q1 2023 Apr 12, 2023	BUY	$144.61 - $166.54 $40,924 - $47,130	283 Added 0.29%	96,457 $15.4 Million
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $13.3 Million - $16 Million	96,174 New	96,174 $0
Q3 2022 Oct 19, 2022	BUY	$134.21 - $153.93 $9.41 Million - $10.8 Million	70,129 Added 281.12%	95,075 $12.8 Million
Q3 2022 Oct 17, 2022	SELL	$134.21 - $153.93 $9.37 Million - $10.8 Million	-69,837 Reduced 73.68%	24,946 $3.35 Million
Q2 2022 Jul 15, 2022	SELL	$137.62 - $174.96 $105,829 - $134,544	-769 Reduced 0.8%	94,783 $14.5 Million
Q1 2022 Apr 21, 2022	BUY	$131.98 - $163.75 $36,822 - $45,686	279 Added 0.29%	95,552 $15.5 Million
Q4 2021 Jan 21, 2022	BUY	$107.43 - $135.93 $174,358 - $220,614	1,623 Added 1.73%	95,273 $12.9 Million
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $18,300 - $20,774	172 Added 0.18%	93,650 $10.1 Million
Q2 2021 Jul 29, 2021	SELL	$105.21 - $117.21 $5,260 - $5,860	-50 Reduced 0.05%	93,478 $10.5 Million
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $34,679 - $38,178	339 Added 0.36%	93,528 $10.1 Million
Q4 2020 Apr 12, 2021	BUY	$80.49 - $108.67 $7.5 Million - $10.1 Million	93,189 New	93,189 $9.99 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayflower Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mayflower Financial Advisors, LLC with notifications on news.

Account

Mayflower Financial Advisors, LLC Abb Vie Inc. Transaction History